Company profile for Prestige BioPharma Pte Ltd

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Prestige BioPharma (PBP) is a Singapore based biopharmaceutical company focusing on development of biosimilars and new antibody therapeutics. PBP has strong presence and networks in Asia Pacific region and actively penetrating into the global pharmaceutical market. The successful completion of phase I clinical trial on its first biosimilar HD201 (Trastuzumab) in EU, 2014, has placed PBP amongst the top-tier biosimilar develope...
Prestige BioPharma (PBP) is a Singapore based biopharmaceutical company focusing on development of biosimilars and new antibody therapeutics. PBP has strong presence and networks in Asia Pacific region and actively penetrating into the global pharmaceutical market. The successful completion of phase I clinical trial on its first biosimilar HD201 (Trastuzumab) in EU, 2014, has placed PBP amongst the top-tier biosimilar developers. The primary focus of current PBP’s R&D is oncology and immune disorders, developing new and similar antibody drugs for solid tumor, pancreatic cancer, and arthritis.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
Singapore
Address
Address
2 Science Park Drive #04-13/14 Ascent Tower B, Singapore Science Park ,118222
Telephone
Telephone
+65 6924 6535
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

DCAT Week

DCAT Week

Not Confirmed

envelop Contact Supplier

DCAT Week

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.prnewswire.com/news-releases/prestige-biopharma-and-biosidus-enter-exclusive-license-agreement-for-tuznue-commercialization-in-latin-america-302626228.html

PR NEWSWIRE
26 Nov 2025

https://www.globenewswire.com/news-release/2025/10/20/3169816/0/en/Teva-and-Prestige-Biopharma-Enter-License-Agreement-for-Tuznue-Commercialization-in-Europe.html

GLOBENEWSWIRE
20 Oct 2025

https://www.ema.europa.eu/en/documents/overview/tuznue-epar-medicine-overview_en.pdf

EMA
19 Sep 2024

https://www.prnewswire.com/news-releases/prestige-biopharmas-herceptin-biosimilar-tuznue-receives-positive-chmp-opinion-from-the-ema-302211174.html

PR NEWSWIRE
31 Jul 2024

https://prestigebiopharma.com/news/?uid=152&mod=document&pageid=1

PRESS RELEASE
22 Sep 2023

https://www.businesswire.com/news/home/20230320005695/en

BUSINESSWIRE
21 Mar 2023

ABOUT THIS PAGE

Contact Prestige BioPharma Pte Ltd and get a quotation

Prestige BioPharma Pte Ltd is a supplier offers 6 products (APIs, Excipients or Intermediates).

Find a price of Amlodipine Besylate bulk offered by Prestige BioPharma Pte Ltd

Find a price of Atorvastatin bulk offered by Prestige BioPharma Pte Ltd

Find a price of Clopidogrel bulk offered by Prestige BioPharma Pte Ltd

Find a price of Olmesartan Medoxomil bulk offered by Prestige BioPharma Pte Ltd

Find a price of Rosuvastatin Calcium bulk offered by Prestige BioPharma Pte Ltd

Find a price of Valsartan bulk offered by Prestige BioPharma Pte Ltd

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty